ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
The Annals of Thoracic Surgery
Volume 82, Issue 3, September 2006, Pages 1033-1037
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (220 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.athoracsur.2006.04.020    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2006 The Society of Thoracic Surgeons Published by Elsevier Inc.

Original article

Modified Approach of Administering Cytostatics to the Lung: More Efficient Isolated Lung Perfusion

Bart P. van Putte MDa, b, e, Corresponding Author Contact Information, E-mail The Corresponding Author, Jeroen M.H. Hendriks MD, PhDb, Gunther Guetens PhDc, d, Gert de Boeck PhDc, Ernst A. de Bruijn PharmDc, Paul E.Y. van Schil MD, PhDb and Gert Folkertse

aDepartment of Cardiothoracic Surgery, St. Antonius Hospital, Nieuwegein, the Netherlands

bDepartment of Thoracic and Vascular Surgery, University Hospital Antwerp, Antwerp, Belgium

cLaboratory of Experimental Oncology, Catholic University Leuven, Leuven, Belgium

dLaboratory of Cancer Research and Clinical Oncology, University of Antwerp, Antwerp, Belgium

eDepartment of Pharmacology and Pathophysiology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, the Netherlands


Accepted 5 April 2006. 
Available online 22 August 2006.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Background

Isolated lung perfusion (ILuP) is an experimental technique for the treatment of pulmonary metastases. We hypothesized that part of the drug taken up by the lung during ILuP is washed out during the flush procedure. Therefore, we investigated gemcitabine uptake at different inflow concentrations, and the effect of delayed clamp release after ILuP on lung levels was studied.

Methods

Thirty rats had ILuP during 30 minutes using gemcitabine perfusate levels of 1.3, 2.7, 4.0, 5.3, and 6.7 mg/mL. Another 37 rats underwent ILuP with gemcitabine perfusate levels of 6.7 mg/mL during 6 minutes followed by a 5-minute flush and 30 or 60 minutes of reperfusion, while two other groups had ILuP and delayed clamp release for 30 or 60 minutes followed by a 5-minute flush. All effluent and lung samples were stored for later analysis. Results were evaluated using Friedmann two-way analysis and two-way analysis of variance.

Results

At 6 minutes, steady-state of gemcitabine uptake was achieved for all inflow concentrations and a linear relation (r = 0.933, p < 0.0001) between effluent and lung levels was observed. Delayed clamp release resulted in significantly higher lung levels compared with immediate restoration of blood circulation after ILuP (456% at 30 minutes and 828% at 60 minutes).

Conclusions

Effective gemcitabine lung levels are already achieved after 6 minutes of ILuP with 6.7 mg/mL followed by delayed clamp release during 30 minutes instead of the clinically applied 30 minutes ILuP.

10

Article Outline

Material and Methods
Animals
Technique of Left Isolated Lung Perfusion
Gemcitabine and Gemcitabine Processing and Measurement
Gemcitabine Assay by High-Performance Liquid Chromatographic-Utraviolet
Experimental Setting
Experiment 1
Experiment 2
Statistics
Results
Comment
Acknowledgements
References





The Annals of Thoracic Surgery
Volume 82, Issue 3, September 2006, Pages 1033-1037
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.